pnb-0408 dihexa human trial Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical dihexa clinical trials status What
Description
Two peptides that both strongly increase GH axis signals can induce excess IGF-1, fluid retention, or glucose dysregulation
Google Scholar Schouten HJ, Geersing GJ, Koek HL
Avoid beverages that can further dehydrate you, such as soda, energy drinks, coffee, and caffeinated teas
The primary endpoint was the percentage change in body weight from baseline to week 26
